Prostate-specific targeting using PSA promoter-based lentiviral vectors (Q45880320)

17 December 2017

title

Prostate-specific targeting using PSA promoter-based lentiviral vectors (English)

1 reference

17 December 2017

author name string

Yu D

1

1 reference

17 December 2017

Chen D

2

1 reference

17 December 2017

Chiu C

3

1 reference

17 December 2017

Razmazma B

4

1 reference

17 December 2017

Chow YH

5

1 reference

17 December 2017

Pang S

6

1 reference

17 December 2017

publication date

1 September 2001

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

628-635

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700344

exact match

0 references

cites work

Treatment of hormone-refractory prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Prostate antigen: A new potential marker for prostatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Relationship between changes in prostate-specific antigen and prognosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

High throughput analysis of differential gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Transcriptionally regulated adenoviruses for prostate-specific gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Relative activity and specificity of promoters from prostate-expressed genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

1 reference

7 January 2021

Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700344

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700344

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017